Search

Search Results

14 results found. Results per page: [ 20 ] [ 40 ] [ 60 ] [ 80 ] [ 100 ] [ 200 ] [ 300 ]

Sort by: [ Publication Date ] [ Score ]

Direction: [ Desc ] [ Asc ]

Year of publication: [ 2026 ] [ 2025 ] [ 2024 ] [ 2023 ] [ 2022 ] [ 2021 ] [ 2020 ] [ 2019 ] [ 2018 ] [ 2017 ] [ 2016 ] [ 2015 ] [ 2014 ] [ 2013 ] [ 2012 ] [ 2011 ] [ 2010 ] [ 2009 ] [ Any ]

• Research PaperVolume 13, Issue 18pp 21866-21902

  Efficacy and safety of current medications for treating severe and non-severe COVID-19 patients: an updated network meta-analysis of randomized placebo-controlled trials

  Relevance score: 0.00

  Qinglin Cheng, Junfang Chen, Qingjun Jia, Zijian Fang, Gang Zhao

  Keywords: efficacy, safety, COVID-19, network meta-analysis, randomized placebo-controlled trials

  Published in Aging on September 16, 2021

  Show abstract
• Research PaperVolume 13, Issue 16pp 20468-20480

  The efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors in treating advanced urothelial cancer: a meta-analysis of clinical trials

  Relevance score: 0.00

  Fei Li, Yu Wang, Kunfeng Xie, Yunze Fang, Yuejun Du, Lina Hou, Wanlong Tan

  Keywords: urothelial cancer, immunotherapy, efficacy, safety, meta-analysis

  Published in Aging on August 23, 2021

  Show abstract
• Research PaperVolume 13, Issue 1pp 450-459

  Comparative efficacy, safety, and acceptability of single-agent poly (ADP-ribose) polymerase (PARP) inhibitors in BRCA-mutated HER2-negative metastatic or advanced breast cancer: a network meta-analysis

  Relevance score: 0.00

  Ju Wang, Ye Zhang, Long Yuan, Lin Ren, Yi Zhang, Xiaowei Qi

  Keywords: ADP-ribose, PARPi, breast cancer, efficacy, network meta-analysis

  Published in Aging on November 30, 2020

  Show abstract
• Research PaperVolume 13, Issue 6pp 8975-8988

  PARP inhibitors in breast and ovarian cancer with BRCA mutations: a meta-analysis of survival

  Relevance score: 0.00

  Fengping Shao, Yaoyun Duan, Yunhe Zhao, Yinguang Li, Jun Liu, Cai Zhang, Shanyang He

  Keywords: PARP inhibitor, BRCA mutation, breast cancer, ovarian cancer, efficacy

  Published in Aging on March 11, 2021

  Show abstract
• Research PaperVolume 13, Issue 11pp 15413-15432

  Sex-related differences in the efficacy of immune checkpoint inhibitors in malignancy: a systematic review and meta-analysis

  Relevance score: 0.00

  Li-Ting Lai, Wei-Guo Gu, Ming-Bin Hu, Wei-Jia Wang, Shan-Shan Wang, Ya-Jun Huai, Jin-Hong Mei, Chun-Liang Wang

  Keywords: immunotherapy, cancer, therapeutic efficacy, sex-specific differences, meta-analysis

  Published in Aging on June 4, 2021

  Show abstract
• ReviewVolume 16, Issue 14pp 11460-11474

  Circulating tumor DNA mutation analysis: advances in its application for early diagnosis of hepatocellular carcinoma and therapeutic efficacy monitoring

  Relevance score: 0.00

  Jing Yang, Na Lin, Miaomiao Niu, Boshu Yin

  Keywords: circulating tumor DNA, hepatocellular carcinoma, early diagnosis, therapeutic efficacy monitoring, high-throughput sequencing

  Published in Aging on July 19, 2024

  Show abstract
• Research PaperVolume 14, Issue 2pp 557-571

  Association between tocilizumab treatment and clinical outcomes of COVID-19 patients: a systematic review and meta-analysis

  Relevance score: 0.00

  Jingwen Peng, Xiaodong She, Huan Mei, Hailin Zheng, Meihua Fu, Guanzhao Liang, Qiong Wang, Weida Liu

  Keywords: tocilizumab, COVID-19, efficacy, meta-analysis, randomized controlled trial

  Published in Aging on January 17, 2022

  Show abstract
• Research PaperVolume 13, Issue 9pp 12691-12709

  Immune subgroup analysis for non-small cell lung cancer may be a good choice for evaluating therapeutic efficacy and prognosis

  Relevance score: 0.00

  Yuan Tian, Jingnan Wang, Qing Wen, Guohai Su, Yuping Sun

  Keywords: immune subgroup, NSCLC, therapeutic efficacy, prognosis

  Published in Aging on May 11, 2021

  Show abstract
• Research PaperVolume 16, Issue 16pp 11955-11969

  Comprehensive multi-omics analysis reveals a combination of lncRNAs that synergistically regulate glycolysis and immunotherapeutic effects in renal clear cell carcinoma

  Relevance score: 0.00

  Yuchen Li, Bowen Hou, Yan Xu, Hongze Li, Yuyan Zhu, Chuize Kong

  Keywords: clear cell renal cell carcinoma, glycolysis, prognosis, immunotherapy efficacy, molecular docking

  Published in Aging on August 19, 2024

  Show abstract
• Research PaperVolume 16, Issue 15pp 11553-11567

  The deubiquitinating enzymes-related signature predicts the prognosis and immunotherapy response in breast cancer

  Relevance score: 0.00

  Youyuan Deng, Jingyong Li, Ye He, Dou Du, Zhiya Hu, Chao Zhang, Qishuo Rao, Yiping Xu, Jianguo Wang, Ke Xu

  Keywords: breast cancer, deubiquitinating enzyme, prognosis, immunotherapy efficacy, OTUB2

  Published in Aging on July 9, 2024

  Show abstract
• Research PaperVolume 13, Issue 21pp 24155-24170

  Development of an immune-related signature for predicting survival outcome and immunotherapy response in osteosarcoma

  Relevance score: 0.00

  Qinghua Wang, Wenjing Zhang, Yuxian Guo, Yuting Li, Kaifeng Fu

  Keywords: osteosarcoma, immune signature, prognosis, immunotherapy efficacy, biomarker

  Published in Aging on November 8, 2021

  Show abstract
• Research PaperVolume 13, Issue 8pp 11120-11134

  High-dose regimens of hypomethylating agents promote transfusion independence in IPSS lower-risk myelodysplastic syndromes: a meta-analysis of prospective studies

  Relevance score: 0.00

  Ziqi Wan, Bing Han

  Keywords: azacytidine, decitabine, lower-risk myelodysplastic syndromes, efficacy, side effects

  Published in Aging on March 26, 2021

  Show abstract
• Research PaperVolume 13, Issue 5pp 6936-6944

  Hypofractionated versus conventionally fractionated image-guided volumetric-modulated arc radiotherapy for localized prostate cancer: a phase II randomized trial from China

  Relevance score: 0.00

  Qiu-Zi Zhong, Xiu Xia, Hong Gao, Yong-Gang Xu, Ting Zhao, Qin-Hong Wu, Dan Wang, Hai-Lei Lin, Xiang-Yan Sha, Ming Liu, Gao-Feng Li

  Keywords: prostate cancer, radiotherapy, IGRT, hypofractionated, toxicity, efficacy

  Published in Aging on February 26, 2021

  Show abstract
• Research PaperVolume 12, Issue 11pp 10827-10843

  High mutation load, immune-activated microenvironment, favorable outcome, and better immunotherapeutic efficacy in melanoma patients harboring MUC16/CA125 mutations

  Relevance score: 0.00

  Qinghua Wang, Yichen Yang, Meng Yang, Xiangchun Li, Kexin Chen

  Keywords: MUC16, tumor mutation load, immune microenvironment, survival outcome, immunotherapeutic efficacy

  Published in Aging on June 3, 2020

  Show abstract